As part of a longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP)will exhibit leading medical breakthroughs in the EHS booth at the annual Arab Health Exhibition and Congress, which is taking place at the Dubai International Convention and Exhibition Centre this week.

New test analyzes mitochondrial DNA to find and quantify certain variations and deletions, providing a useful diagnostic tool that helps guide treatment.

CHOP researchers found that levels of proteins in the plasma of patients with MIS-C are significantly dysregulated and share features with two other inflammatory syndromes.

CHOP researchers have found that implementation science is underused in pediatric oncology and call for more research in this area to improve patient care.

CHOP researchers found rising temperatures due to climate change will lead to an increase in cases of kidney stones over the next seven decades.

CHOP researchers have found infants born via uncomplicated cesarean delivery should not need antibiotics at birth to prevent early-onset sepsis.

CHOP researchers have found that indicators of lower socioeconomic status are associated with an increased risk of cleft lip with or without cleft palate.

Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.

CHOP's Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE) study was recently awarded funding from the Patient-Centered Outcomes Research Institute (PCORI). PRESERVE is a three-year, multi-institutional clinical trial evaluating blood pressure management and urine protein monitoring strategies to preserve kidney function in pediatric chronic kidney disease (CKD) patients.

Researchers have unlocked patterns to improve the diagnosis of the most common epigenetic childhood cancer disorder.